Tomas Benito‐González

ORCID: 0000-0002-8428-9248
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Atrial Fibrillation Management and Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Acute Myocardial Infarction Research
  • Mechanical Circulatory Support Devices
  • Aortic Disease and Treatment Approaches
  • Aortic aneurysm repair treatments
  • Acute Ischemic Stroke Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac electrophysiology and arrhythmias
  • COVID-19 Clinical Research Studies
  • Cardiac tumors and thrombi
  • Cardiac, Anesthesia and Surgical Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Health and Mental Health
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Issues in Pregnancy
  • Health Systems, Economic Evaluations, Quality of Life
  • Heart Failure Treatment and Management

Hospital de León
2016-2025

Complejo Asistencial Universitario de Palencia
2017-2025

Hospital Universitario Lucus Augusti
2024

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2024

Centro de Investigación en Red en Enfermedades Cardiovasculares
2022

Centro de Investigación Biomédica en Red
2022

University Hospital Complex Of Vigo
2021

Hospital Universitario del Vinalopó
2021

Complejo Hospitalario de Salamanca
2021

Sociedad Española de Cardiología
2021

[Figure: see text].

10.1161/circep.120.009458 article EN other-oa Circulation Arrhythmia and Electrophysiology 2021-02-08
Jörg Hausleiter Mark Lachmann Lukas Stolz Francesco Bedogni Antonio Popolo Rubbio and 95 more Rodrigo Estévez‐Loureiro Sergio Raposeiras‐Roubín Peter Boekstegers Nicole Karam Volker Rudolph Thomas J. Stocker Mathias Orban Daniel Braun Michael Näbauer Steffen Maßberg Aniela Popescu T. Ruf Ralph Stephan von Bardeleben Christos Iliadis Roman Pfister Stephan Baldus Christian Besler Tobias Kister Karl Patrik Kresoja Philipp Lurz Hölger Thiele Benedikt Koell Niklas Schofer Daniel Kalbacher Michael Neuß Christian Butter Karl‐Ludwig Laugwitz Teresa Trenkwalder Eroion Xhepa Michael Joner Hazem Omran Vera Fortmeier Muhammed Gerçek Harald Beucher Thomas Schmitz Alexander Bufe Jürgen Rothe Melchior Seyfarth Tobias Schmidt Christian Frerker Dennis Rottländer Patrick Horn Maximilian Spieker Elric Zweck Mohammad Kassar Fabien Praz Stephan Windecker Tania Puscas Marianna Adamo L Lupi Marco Metra Emmanuel Villa Giuseppe Biondi‐Zoccai Corrado Tamburino Carmelo Grasso Fausto Catriota Luca Testa Maurizio Tusa Cosmo Godino Michele Galasso Matteo Montorfano Eustachio Agricola Paolo Denti Federico De Marco Giuseppe Tarantini Giulia Masiero Gabriele Crimi Andrea Munafò Christina Giannini Anna Sonia Petronio Stefano Pidello Paolo Boretto Antonio Montefusco Simone Frea Filippo Angelini Pier Paolo Bocchino Francesco De Felice Rodolfo Citro Berenice Caneiro‐Queija Xavier Freixa Ander Regueiro Laura Sanchís Manel Sabaté Dabit Arzamendi Lluís Asmarats Estefanía Fernández‐Peregrina Tomas Benito‐González Felipe Fernández‐Vázquez Isaac Pascual Pablo Avanzas Luis Nombela‐Franco Gabriela Tirado‐Conte Eduardo Pozo A Portoles Vanessa Moñivas Palomero

Abstract Background and Aims Risk stratification for mitral valve transcatheter edge-to-edge repair (M-TEER) is paramount in the decision-making process to appropriately select patients with severe secondary regurgitation (SMR). This study sought develop validate an artificial intelligence-derived risk score (EuroSMR score) predict 1-year outcomes (survival or survival + clinical improvement) SMR undergoing M-TEER. Methods An was developed from EuroSMR cohort (4172 428 treated M-TEER...

10.1093/eurheartj/ehad871 article EN European Heart Journal 2024-01-19

The aim of this study was to evaluate the outcome transcatheter mitral valve repair (TMVr) in patients with cardiogenic shock and significant regurgitation (MR). Patients severe MR have a poor prognosis setting conventional medical therapy. Because its favorable safety profile, TMVr is being increasingly used as an acute therapy population, though efficacy remains unknown. A multicenter, collaborative, patient-level analysis conducted. moderate (3+) or (4+) who were not surgical candidates...

10.1016/j.jcin.2020.08.037 article EN cc-by-nc-nd КАРДИОЛОГИЯ УЗБЕКИСТАНА 2020-10-14

Severe mitral regurgitation (MR) following acute myocardial infarction (MI) is associated with high mortality rates and has inconclusive recommendations in clinical guidelines. We aimed to report the international experience of patients secondary MR MI compare outcomes those treated conservatively, surgically, percutaneously.Retrospective registry consecutive at least moderate-to-severe 21 centres North America, Europe, Middle East. The included conservatively having surgical valve repair or...

10.1093/eurheartj/ehab496 article EN European Heart Journal 2021-07-23

Intravascular lithotripsy (IVL) has demonstrated effectiveness in the treatment of calcified lesions selected patients with stable coronary disease.

10.1016/j.jcin.2023.12.018 article EN cc-by КАРДИОЛОГИЯ УЗБЕКИСТАНА 2024-02-21

Abstract Objectives To assess outcomes in patients with acute mitral regurgitation (MR) following myocardial infarction (AMI) who received percutaneous valve repair (PMVR) the MitraClip device and to compare of developed cardiogenic shock (CS) those did not (non‐CS). Background Acute MR after AMI may lead CS is associated high mortality. Methods This registry analyzed were treated at 18 centers within eight countries between January 2016 February 2020. Patients stratified into non‐CS groups....

10.1002/ccd.29552 article EN Catheterization and Cardiovascular Interventions 2021-02-18

Background: Transcatheter mitral valve repair (TMVR) is an effective therapy for high-risk patients with severe regurgitation (MR) but heart failure (HF) readmissions and death remain substantial on mid-term follow-up. Recently, right ventricular (RV) to pulmonary arterial (PA) coupling has emerged as a relevant prognostic predictor in HF. In this study, we aimed assess the value of tricuspid annular plane systolic excursion (TAPSE) PA pressure (PASP) ratio non-invasive measure RV-to-PA...

10.3390/jcm10051006 article EN Journal of Clinical Medicine 2021-03-02

Importance Patients with atrial fibrillation (AF) who have ischemic stroke despite taking oral anticoagulation therapy (OAT) a very high risk of recurrence. Left appendage occlusion (LAAO) is mechanical prevention strategy that may provide additional protection in patients thromboembolic events under OAT. Objective To compare percutaneous LAAO continuing OAT alone regarding AF had event Design, Setting, and Participants This cohort study was propensity score–matched comparison the STR-OAC...

10.1001/jamaneurol.2024.2882 article EN JAMA Neurology 2024-09-23

Significant tricuspid regurgitation (TR) is associated with increased morbidity and mortality. The development of transcatheter valve repair therapies has opened a wide range opportunities for treatment patients high surgical risk. Real-world data might improve patient selection outcome. authors sought to investigate acute short-term cardiovascular outcomes edge-to-edge (T-TEER) dedicated devices in real-world setting. This retrospective, single-arm, multicenter registry conducted at 15...

10.1161/jaha.124.037070 article EN cc-by-nc-nd Journal of the American Heart Association 2025-01-17
Coming Soon ...